ImmunoPET for prostate cancer in the PSMA era: do we need other targets?
ConclusionImmunoPET pre-clinical studies have identified several biomarkers with potentially high impact on PC theranostics.
Source: Clinical and Translational Imaging - Category: Radiology Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Neurology | Prostate Cancer | Radiology | Stem Cell Therapy | Stem Cells | Study